$1.5 million for adult stem cell study in Australia Australian mature stem cell company, Mesoblast Limited, announced that its chief scientific advisor and founder today, Professor Silviu Itescu, has been awarded a $1.5 million grant for pre-clinical and clinical development of mesenchymal lineage adult stem cells.5 million allocation being made under a particular Memorandum of Understanding. The Chairman of Mesoblast, Mr Michael Spooner, indicated that at the mercy of materials transfer agreements, Mesoblast would provide its specialist Mesenchymal Precursor Cells for these and other Government and industrysponsored research..Kaiser Family Foundation. Copyright 2009 Advisory Board Business and Kaiser Family Foundation. All rights reserved.
ASBP concerned over FDA rejection of Contrave drug The American Culture of Bariatric Doctors can be involved that the FDA recently rejected the weight-reduction drug Contrave, contradicting the FDA advisory panel’s recommendation for approval. ASBP’s physicians treat obesity and obesity-related co-morbidities on a daily basis and believe the FDA’s specifications for approving anti-obesity medicines are overly stringent and fail to recognize the health risks connected with carrying additional weight.